HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guido Grassi Selected Research

Brain Natriuretic Peptide (Natrecor)

1/2022Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study.
2/2015Effects of multielectrode renal denervation on cardiac and neurohumoral adaptations in resistant hypertension with cardiac hypertrophy: an EnligHTN I substudy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guido Grassi Research Topics

Disease

143Hypertension (High Blood Pressure)
03/2024 - 03/2002
33Heart Failure
09/2023 - 06/2004
30Obesity
10/2023 - 09/2003
21Cardiovascular Diseases (Cardiovascular Disease)
03/2024 - 12/2003
19Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2023 - 11/2006
14Stroke (Strokes)
11/2023 - 06/2002
13Chronic Renal Insufficiency
01/2024 - 07/2009
13Essential Hypertension
12/2021 - 10/2002
11Insulin Resistance
03/2024 - 09/2003
10Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2024 - 08/2008
9Type 2 Diabetes Mellitus (MODY)
12/2024 - 10/2011
8Weight Loss (Weight Reduction)
12/2024 - 04/2010
8Hypertrophy
11/2022 - 01/2006
8Renal Insufficiency (Renal Failure)
01/2021 - 09/2004
7Hyperuricemia
01/2024 - 11/2017
7COVID-19
01/2022 - 01/2020
7Disease Progression
01/2020 - 04/2009
7Cardiomegaly (Heart Hypertrophy)
09/2015 - 11/2006
6Body Weight (Weight, Body)
11/2021 - 08/2005
6Atrial Fibrillation
06/2021 - 03/2003
5Atherosclerosis
10/2022 - 11/2012
5Myocardial Infarction
04/2022 - 12/2019
4Kidney Diseases (Kidney Disease)
09/2023 - 10/2018
4Metabolic Diseases (Metabolic Disease)
02/2023 - 01/2006
4White Coat Hypertension
10/2022 - 08/2011
4Fibrosis (Cirrhosis)
11/2021 - 05/2005
4Diabetes Mellitus
01/2020 - 08/2008
4Obstructive Sleep Apnea
01/2019 - 08/2005
4Isolated Systolic Hypertension
01/2018 - 06/2015
4Abdominal Obesity
06/2015 - 12/2004
3Chronic Kidney Failure (Chronic Renal Failure)
01/2024 - 03/2009
3Dyslipidemias (Dyslipidemia)
05/2023 - 03/2022
3Coronary Artery Disease (Coronary Atherosclerosis)
03/2022 - 01/2015
3Left Ventricular Dysfunction
01/2022 - 08/2011
3Carotid Artery Diseases
01/2021 - 06/2009
3Overweight
01/2019 - 07/2009
3Masked Hypertension
07/2015 - 08/2009
2Inflammation (Inflammations)
03/2024 - 01/2022
2Coronary Disease (Coronary Heart Disease)
11/2023 - 04/2022
2Acute Coronary Syndrome
09/2023 - 03/2022
2Hypertriglyceridemia
02/2023 - 06/2021
2Hypercholesterolemia
03/2022 - 06/2005
2Atherosclerotic Plaque (Atheroma)
03/2022 - 06/2021
2Takotsubo Cardiomyopathy
01/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

53Antihypertensive Agents (Antihypertensives)IBA
03/2024 - 03/2002
36Adrenergic Agents (Adrenergic Drugs)IBA
01/2021 - 03/2003
22Glucose (Dextrose)FDA LinkGeneric
03/2024 - 09/2003
21Uric Acid (Urate)IBA
01/2024 - 06/2014
19Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2021 - 09/2004
14CholesterolIBA
11/2022 - 06/2005
13DiureticsIBA
03/2024 - 09/2003
12LipidsIBA
01/2024 - 01/2010
12Blood Glucose (Blood Sugar)IBA
01/2021 - 06/2005
11Triglycerides (Triacylglycerol)IBA
03/2024 - 05/2010
11Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2022 - 01/2016
8Drug CombinationsIBA
11/2023 - 09/2004
8LDL CholesterolIBA
11/2022 - 09/2014
7Biomarkers (Surrogate Marker)IBA
03/2024 - 08/2008
7Calcium Channel Blockers (Blockers, Calcium Channel)IBA
03/2024 - 01/2006
7Hypoglycemic Agents (Hypoglycemics)IBA
03/2023 - 06/2005
7Retinaldehyde (Retinal)IBA
01/2021 - 05/2006
6Insulin (Novolin)FDA Link
03/2024 - 09/2003
6HDL CholesterolIBA
01/2024 - 06/2010
6Angiotensin Receptor AntagonistsIBA
11/2021 - 09/2003
6ReninIBA
01/2019 - 09/2004
5CreatinineIBA
01/2023 - 01/2019
5AngiotensinsIBA
01/2019 - 03/2006
5AldosteroneIBA
01/2018 - 05/2005
4SodiumIBA
11/2023 - 10/2010
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2023 - 11/2011
4Atenolol (Tenormin)FDA LinkGeneric
12/2022 - 12/2003
4lercanidipineIBA
10/2017 - 01/2006
4Hydrochlorothiazide (Esidrix)FDA LinkGeneric
01/2017 - 09/2003
4LeptinIBA
08/2015 - 11/2006
3oxidized low density lipoproteinIBA
01/2023 - 09/2014
3Metoprolol (Toprol-XL)FDA LinkGeneric
12/2022 - 10/2013
3Ethanol (Ethyl Alcohol)IBA
11/2022 - 01/2020
3lacidipineIBA
10/2022 - 01/2019
3CatecholaminesIBA
01/2022 - 10/2019
3pro-brain natriuretic peptide (1-76)IBA
01/2022 - 02/2015
3Peptides (Polypeptides)IBA
01/2017 - 09/2011
3NebivololFDA Link
01/2017 - 12/2003
2Sodium-Glucose Transporter 2 InhibitorsIBA
12/2024 - 01/2022
2MicroRNAs (MicroRNA)IBA
03/2024 - 01/2022
2Angiotensin Receptors (Angiotensin II Receptor)IBA
11/2023 - 01/2017
2ElementsIBA
09/2023 - 06/2009
2pitavastatin (itavastatin)FDA Link
03/2023 - 03/2022
2Lipoproteins (Lipoprotein)IBA
01/2023 - 11/2012
2Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
10/2022 - 01/2006
2Anti-Bacterial Agents (Antibiotics)IBA
05/2022 - 01/2019
2SolutionsIBA
05/2022 - 02/2004
2AlbuminsIBA
01/2022 - 01/2020
2Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022 - 02/2015

Therapy/Procedure

35Therapeutics
03/2024 - 11/2004
20Denervation
03/2024 - 01/2012
4Secondary Prevention
03/2022 - 06/2002
3Catheters
10/2023 - 05/2012
3Glycemic Control
01/2021 - 12/2013
3Bariatric Surgery
10/2014 - 06/2012
2Diet Therapy (Therapy, Diet)
11/2023 - 01/2018